How do medtech companies build awareness for complex, highly regulated therapies when they're not something consumers can “add to cart”? Naomi Rodiles, Medtronic 's senior director of global integrated communications, neuromodulation, shared how her team is working to responsibly grow patient awareness and understanding for neuromodulation therapies like deep brain stimulation that can support management of movement disorders such as Parkinson’s. She explains why awareness itself is often the real growth constraint for complex offerings, and what “digital first” can mean in medtech when the goal is helping patients and caregivers find clear, credible information when they start searching. Jump to the link in our bio to learn more in the full episode of Deloitte Digital’s podcast Marketing Beyond with Alan Hart. #DDPodcasts